The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth is a research paper published in Neuro-Oncology Advances (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1R25CA240122
Animal Imaging Shared Resource
Grant: P30CA046934
The Skin Diseases Research Cores
Grant: P30AR057212
NCI NIH HHS
Grant: R25 CA240122
NIH HHS
Grant: S10 OD023485
NIH HHS
Grant: S10 OD027023
National Institutes of Health
Grant: 5P30AR057212-03
Molecular Analysis, Modeling and Correction of Skin Diseases
National Institutes of Health
Grant: 5R25CA240122-03
Cancer Research Experiences for Undergraduates (CREU)
National Institutes of Health
Grant: 3P30CA046934-20S2
Cancer Center Support Grant
Research Histology Division
University of Colorado Pathology Shared Resource
University of Colorado Cancer Center
Cancer Center Flow Cytometry Shared Resource
Fields of Study
Keywords
Sustainable Development Goals